Valuation : Maravai LifeSciences Holdings, Inc.

Market Cap 1.09B 938M 883M 804M 1.51B 103B 1.52B 10.43B 4.06B 52.51B 4.08B 3.99B 174B P/E 2026 *
-23.7x
P/E 2027 * -30.7x
Enterprise Value 1.14B 980M 922M 840M 1.58B 108B 1.59B 10.9B 4.24B 54.86B 4.27B 4.17B 182B EV / Sales 2026 *
5.37x
EV / Sales 2027 * 4.82x
Free-Float
45.44%
Yield 2026 *
-
Yield 2027 * -
1 day-4.45%
1 week-18.89%
Current month-4.45%
1 month+11.11%
3 months+53.68%
6 months+105.06%
Current year+124.62%
1 week 7.28
Extreme 7.28
8.98
1 month 5.41
Extreme 5.41
9.42
Current year 2.8
Extreme 2.8
9.42
1 year 2.3
Extreme 2.3
9.42
3 years 1.66
Extreme 1.665
11.56
5 years 1.66
Extreme 1.665
61.02
10 years 1.66
Extreme 1.665
63.55
Manager TitleAgeSince
Chief Executive Officer 59 2025-06-07
Director of Finance/CFO 59 2025-06-29
Chief Operating Officer - 2025-07-31
Director TitleAgeSince
Director/Board Member 50 2016-02-29
Director/Board Member 65 2020-10-31
Director/Board Member 61 2019-12-31
Date Insider Type Main position Quantity % Market Cap. Importance
8/10/26 Tax

Chief Executive Officer

-29,250 0.0198%
7/30/26 Tax

Chief Financial Officer

-5,465 0.0037%
7/8/26 Tax

Chief Executive Officer

-29,250 0.0198%
Change 5-day change 1-year change 3-year change Capi.($)
-4.45%-18.89%+201.65%-29.13% 1.09B
-2.33%-7.28%+84.67%+257.42% 3.88B
+1.35%-1.90%+271.30%+34.63% 3.75B
+0.56%-1.39%+43.14%+62.66% 3.49B
-2.27%-3.60%+258.49%+403.29% 2.53B
-0.44%-4.84%-28.21%-28.01% 2.21B
+3.11%+9.01%+44.15% - 1.64B
-1.79%+4.93%+29.16%+49.32% 1.1B
-0.97%-6.23%+24.88%+68.14% 642M
+0.43%-3.15%-34.90%-3.53% 537M
Average -0.95%-3.66%+89.43%+90.53% 2.09B
Weighted average by Cap. -1.00%-3.37%+115.49%+123.36%

Financials

2026 *2027 *
Net sales 212M 183M 172M 156M 294M 20.08B 296M 2.03B 790M 10.21B 794M 777M 33.87B 226M 195M 183M 167M 314M 21.42B 315M 2.17B 843M 10.9B 848M 829M 36.13B
Net income -48.85M -42.14M -39.64M -36.11M -67.91M -4.64B -68.27M -469M -182M -2.36B -183M -179M -7.82B -33.6M -28.98M -27.26M -24.83M -46.7M -3.19B -46.95M -322M -125M -1.62B -126M -123M -5.38B
Net Debt 48.8M 42.09M 39.6M 36.07M 67.83M 4.63B 68.2M 468M 182M 2.36B 183M 179M 7.81B -385K -332K -313K -285K -536K -36.56M -538K -3.7M -1.44M -18.6M -1.45M -1.42M -61.67M
Logo Maravai LifeSciences Holdings, Inc.
Maravai LifeSciences Holdings, Inc. is a life sciences company providing critical products and services to enable the development of drugs, therapeutics, vaccines, and diagnostics, and support research on human disease. Its segments include TriLink and Cygnus. Its TriLink segment provides nucleic acid products and related services, including messenger ribonucleic acid (mRNA), oligonucleotides, CleanCap mRNA capping technology, ModTail poly(A) tail modification technology, synthesis inputs, nucleoside triphosphates, enzymes, and mRNA manufacturing services. Its Cygnus segment provides biologics safety testing products and services, including host cell protein enzyme-linked immunosorbent assay (ELISA) kits, impurity detection assays, viral clearance prediction tools, ancillary reagents, and custom analytical services. Its TriLink and Cygnus segments produce materials used in research and biopharmaceutical production, clinical trial vaccines and vaccine support products.
Employees
415
Date Price Change Volume
26-09-01 US$7.300 -4.45% 2,698,378
26-08-31 US$7.640 -0.52% 5,318,132
26-08-28 US$7.680 -8.24% 5,564,528
26-08-27 US$8.370 -5.96% 3,174,523
26-08-26 US$8.900 -1.11% 5,539,075
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
7.300USD
Average target price
7.300USD
Spread / Average Target
0.00%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. MRVI Stock